The new CERN-MEDICIS facility has produced radioisotopes for medical research for the first time. MEDICIS (Medical Isotopes Collected from ISOLDE) aims to provide a wide range of radioisotopes, some of which can be produced only at CERN1 thanks to the unique ISOLDE facility. These radioisotopes are destined primarily for hospitals and research centres in Switzerland and across Europe.
At
ISOLDE, the high-intensity proton beam from CERN’s Proton Synchrotron Booster
(PSB) is directed onto specially developed thick targets, yielding a large
variety of atomic fragments. Different devices are used to ionise, extract and
separate nuclei according to their mass, forming a low-energy beam that is
delivered to various experimental stations. MEDICIS works by placing a second
target behind ISOLDE’s. Once the isotopes have been produced at the MEDICIS
target, an automated conveyor belt carries them to the MEDICIS facility, where
the radioisotopes of interest are extracted through mass separation and
implanted in a metallic foil. They are then delivered to research facilities
including the Paul Scherrer Institut (PSI), the Department of Nuclear Medicine
and Molecular Imagining at the University Hospital of Vaud (CHUV) and the
Geneva University Hospitals (HUG).
This release was first published
on 12 December 2017 by CERN.
To
read more please visit: https://sciencebusiness.net/network-news/new-cern-facility-can-help-medical-research-cancer
Source: Science Business